|
Sign In to gain access to subscriptions and/or personal tools.
|
Potential Modern Alternative Designs for Caries Clinical Trials (CCTs) and How These can be Validated against the Conventional Model
R.K. Chesters1,*,
R.P. Ellwood2,
A.R. Biesbrock3 and
S.R. Smith4
1 Unilever Dental Research, Port Sunlight, Bebington, UK;
2 Colgate Palmolive, Dental Health Unit, Manchester, UK;
3 Procter & Gamble Co., Cincinnati, OH, USA; and
4 GlaxoSmithKline, Weybridge, UK;

View larger version (14K):
[in this window]
[in a new window]
|
Figure 1. Cross-sectional caries prevalence (DMFT) in 1983 and 1993 for children in areas of the United Kingdom with different caries attack rates. Data taken from National Surveys (OBrien, 1994; Todd and Dodd, 1985)
|
|

View larger version (10K):
[in this window]
[in a new window]
|
Figure 2. Cell size as a function of predicted caries increment for control group. (Data supplied by Unilever Dental Research.)
|
|

View larger version (13K):
[in this window]
[in a new window]
|
Figure 3. Predicted two-year caries increment (DMFT) for different ages at baseline, derived from cross-sectional data.
|
|

View larger version (20K):
[in this window]
[in a new window]
|
Figure 4. Fluoride dose response. Shows caries increments in three- or four-year clinical trials comparing similar toothpastes with different fluoride levels (Clarkson et al., 1993).
|
|
Journal of Dental Research, Vol. 83, No. suppl 1,
C122-C124 (2004)
DOI: 10.1177/154405910408301S26

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
|
|